OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 31, 2019
Daiichi Sankyo Europe has revealed the results of a Phase III study assessing the efficacy, safety, and tolerability of bempedoic acid/ezetimibe fixed-dose combination (FDC) tablet.
Neuraxpharm Group has announced it is launching its first products in the United Kingdom.
July 29, 2019
Iontas and Teva Pharmaceuticals have entered into an agreement for the application of technologies and know-how into the optimization of human antibodies to be used as biotherapeutics.
July 24, 2019
Cure Pharmaceutical secured a patent that lets the company load higher drug amounts to its proprietary drug delivery system, CUREfilm.
July 17, 2019
Lonza plans to implement MES software to accelerate paperless, 24/7 production of drug capsules.
July 16, 2019
Suheung’s new facility in Vietnam is dedicated to vegetarian capsule manufacturing.
An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.
July 02, 2019
Several trends are driving change in oral solid‑dosage forms and giving rise to the requirement of ‘fit-for-purpose’ excipients.
July 01, 2019
More than 30 lots of losartan drug products have been recalled due to contaminated API manufactured by Hetero Labs.
Novavax will sell two Maryland-based vaccine development and manufacturing facilities for Catalent’s expanding gene therapy footprint.